Pharmaceutical

Earnings Summary – Akums Drugs & Pharmaceuticals Reports 14.8% Revenue Growth in Q3 FY26 Results

● Feb 15, 2026

Akums Drugs and Pharmaceuticals Limited (NSE: AKUMS), a pharmaceutical contract development and manufacturing organization (CDMO) announced its third-quarter and nine-month...

Alkem Laboratories Posts 11% Revenue Growth in Q3 FY26 Amid Strategic MedTech Push

● Feb 13, 2026

Alkem Laboratories Ltd. (NSE: ALKEM), a major Indian pharmaceutical player, reported solid unaudited financial results for the third quarter ended...

Earnings Summary – Lupin Limited Reports 26.4% Revenue Growth in Third Quarter FY2026

● Feb 13, 2026

Lupin Limited (NSE: LUPIN) is a global pharmaceutical company specializing in branded and generic formulations, biotechnology, and active pharmaceutical ingredients....

ZIM Laboratories Q3FY26 profit rebounds on export-led growth; margins steady amid ongoing remediation and R&D push

● Feb 12, 2026

ZIM Laboratories Limited (NSE:ZIMLAB), an India-based pharmaceutical formulations and nutraceutical company focused on oral thin films (OTF), innovative drug delivery...

Marksans Pharma Reports Q3FY26 with Revenue Growth and EBITDA Margin Expansion

● Feb 6, 2026

About Marksans Pharma Limited Marksans Pharma Limited (NSE: MARKSANS) is an Indian pharmaceutical company headquartered in Mumbai, India, founded in...

Emcure Pharmaceuticals Q3 FY26 Earnings Results

● Feb 5, 2026

Executive Summary Emcure Pharmaceuticals Ltd reported Q3FY26 revenues of ₹2,363 crore, up 20.38% YoY, with consolidated net profit surging 48.08%...

Mankind Pharma Q3 FY26 Earnings Results

● Feb 3, 2026

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and...

Corona Q3 FY26 Earnings Results

● Feb 3, 2026

Executive Summary Corona Remedies Ltd reported Q3FY26 revenues of ₹342 crore, up 14.37% YoY, with consolidated net profit increasing 39.13%...

Sun Pharmaceutical Q3 FY26 Earnings Results

● Feb 2, 2026

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and...

Gland Pharma Q3 FY26 Earnings Results

● Jan 29, 2026

Executive Summary Gland Pharma Ltd reported Q3FY26 revenues of ₹1,695 crore, up 22.47% YoY, with consolidated net profit rising 27.32%...